Melanoma Regression and Recurrence in Zebrafish.
Melanoma Regression and Recurrence in Zebrafish.
复制标题
DOI:
10.1007/978-1-4939-3771-4_10
复制
发表时间:
2016
影响因子:
--
通讯作者:
S. Wojciechowska;Zhiqiang Zeng;J. Lister;C. Ceol;E. Patton
中科院分区:
文献类型:
--
作者:
S. Wojciechowska;Zhiqiang Zeng;J. Lister;C. Ceol;E. Patton
Melanoma is the most lethal form of skin cancer with high mortality rates. Most melanoma cases have activating mutations in BRAF (V600E) and the selective inhibitors of BRAFV600Ehave been successfully used in patients. However, after initial tumor regression, the majority of patients develop drug resistance resulting in tumor regrowth. It is therefore important to understand the mechanisms underlying these processes. We have recently described the role of the master melanocyte transcription factor MITF in tumor growth, regression, and recurrence. Here, we describe protocols to study regression and recurrence in vivo, as well as for histology and immunohistochemistry, using a temperature-sensitive zebrafish model of human melanoma.